PBAXW
Income statement / Annual
Last year (2024), Phoenix Biotech Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Phoenix Biotech Acquisition Corp.'s net income was -$11.09 M.
See Phoenix Biotech Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$254.83 K
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
Research and Development Expenses |
$7.08 M
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$9.12 M
|
$2.84 M
|
$431.50
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$251.27 K
|
Selling, General & Administrative Expenses |
$9.12 M
|
$2.84 M
|
$251.71 K
|
Other Expenses |
$0.00
|
$64.05 K
|
-$80.32 K
|
Operating Expenses |
$16.20 M
|
$2.91 M
|
$332.03 K
|
Cost And Expenses |
$0.00
|
$2.91 M
|
$332.03 K
|
Interest Income |
$0.00
|
$2.84 M
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$0.00
|
-$5.67 M
|
$236.56 K
|
EBITDA |
-$16.20 M |
-$5.74 M |
-$332.03 K |
EBITDA Ratio |
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
Total Other Income/Expenses Net |
$5.11 M
|
$2.84 K
|
-$385.00
|
Income Before Tax |
-$11.09 M
|
-$68.58 K
|
-$332.42 K
|
Income Before Tax Ratio |
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$599.16 K
|
-$16.87 K
|
Net Income |
-$11.09 M
|
-$667.74 K
|
-$315.55 K
|
Net Income Ratio |
0
|
0
|
0
|
EPS |
-0.22 |
-0.0099 |
-0.0046 |
EPS Diluted |
-0.22 |
-0.0099 |
-0.0046 |
Weighted Average Shares Out |
$49.68 M
|
$67.48 M
|
$68.94 M
|
Weighted Average Shares Out Diluted |
$49.68 M
|
$67.48 M
|
$68.94 M
|
Link |
|
|
|